Jane F. Barlow's most recent trade in Sera Prognostics Inc - Ordinary Shares Class A was a trade of 25,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sera Prognostics Inc - Ord... | Jane F. Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Sera Prognostics Inc - Ord... | Jane F. Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 15,596 | 22,713 | - | 0 | Class A Common Stock | |
| Viracta Therapeutics Inc | Jane F. Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sera Prognostics Inc - Ord... | Jane F. Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 10,549 | 10,549 | - | - | Stock Option (right to buy) | |
| Sera Prognostics Inc - Ord... | Jane F. Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,117 | 7,117 | - | 0 | Class A Common Stock | |
| Sera Prognostics Inc - Ord... | Jane F. Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 63,265 | 63,265 | - | - | Stock Option (right to buy) | |
| Viracta Therapeutics Inc | Jane F. Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Viracta Therapeutics Inc | Jane F. Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| ContraFect Corp | Jane F. Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 42,000 | 42,000 | - | - | Options (Right to Buy) | |
| Sera Prognostics Inc - Ord... | Jane F. Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2022 | 140,823 | 140,823 | - | - | Stock Option (right to buy) | |
| Viracta Therapeutics Inc | Jane F. Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| ContraFect Corp | Jane F. Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 16,000 | 16,000 | - | - | OPTIONS (RIGHT TO BUY) |